STE - STERIS plc
NYSE
->
Healthcare
->
Medical Devices
Dublin,
Ireland
Type: Equity
STE price evolution
STE
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $198.33 | $207.02 | $195.59 | |
| Short term investments | ||||
| Net receivables | $923.34 | $892.61 | $1008.32 | $964.02 |
| Inventory | $688.93 | $698.59 | $674.53 | $855.62 |
| Total current assets | $1937.87 | $1940.49 | $2875.54 | $2218.95 |
| Long term investments | ||||
| Property, plant & equipment | $2088.9 | $1999.24 | $1938.38 | $2039.9 |
| Goodwill & intangible assets | $6105.74 | $6189.99 | $7098.97 | |
| Total noncurrent assets | $8168.11 | $8194.57 | $9216.2 | |
| Total investments | ||||
| Total assets | $10242.15 | $10108.6 | $11071.84 | $11435.16 |
| Current liabilities | ||||
| Accounts payable | $235.07 | $231.72 | $251.72 | $276.73 |
| Deferred revenue | ||||
| Short long term debt | $109.7 | $117.18 | $115.15 | |
| Total current liabilities | $805.48 | $834.36 | $939.27 | $913.69 |
| Long term debt | $2156.16 | $2235.6 | $3120.16 | $3393.9 |
| Total noncurrent liabilities | $2903.8 | $3817.22 | $4093.36 | |
| Total debt | $2484.67 | $3383.17 | $3509.05 | |
| Total liabilities | $3648.66 | $3754 | $4756.49 | $5007.06 |
| Shareholders' equity | ||||
| Retained earnings | $2268.33 | $2178.09 | $2087.64 | $2133.77 |
| Other shareholder equity | -$165.84 | -$323.07 | $6315.35 | -$252.63 |
| Total shareholder equity | $6354.6 | $6302.16 | $6415.4 | |
| (in millions $) | 31 Dec 2024 | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $207.02 | $208.36 | $348.32 | $220.53 |
| Short term investments | ||||
| Net receivables | $1008.32 | $928.32 | $799.04 | $609.41 |
| Inventory | $674.53 | $695.49 | $575 | $315.07 |
| Total current assets | $2869.12 | $2011.44 | $1879 | $1211.75 |
| Long term investments | ||||
| Property, plant & equipment | $1938.38 | $1897.25 | $1741.06 | $1385.54 |
| Goodwill & intangible assets | $6189.99 | $6835 | $7732.88 | $3924.45 |
| Total noncurrent assets | $8194.57 | $8810.4 | $9544.6 | $5362.72 |
| Total investments | ||||
| Total assets | $11063.7 | $10821.84 | $11423.59 | $6574.47 |
| Current liabilities | ||||
| Accounts payable | $251.72 | $279.62 | $225.74 | $156.95 |
| Deferred revenue | ||||
| Short long term debt | $117.18 | $94.96 | $179.35 | $22.77 |
| Total current liabilities | $931.13 | $861.84 | $922.22 | $577.92 |
| Long term debt | $3265.99 | $3179.15 | $3100.54 | $1780.21 |
| Total noncurrent liabilities | $3817.22 | $3872.82 | $3956.74 | $2105.08 |
| Total debt | $3383.17 | $3274.11 | $3279.88 | $1802.99 |
| Total liabilities | $4748.35 | $4734.67 | $4878.96 | $2683 |
| Shareholders' equity | ||||
| Retained earnings | $2087.64 | $1911.53 | $1999.24 | $1939.41 |
| Other shareholder equity | -$328.66 | -$320.71 | -$209.81 | -$61.24 |
| Total shareholder equity | $6302.16 | $6077.2 | $6532.36 | $3880.99 |
| (in millions $) | 30 Jul 2025 | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1279.5 | $1116.15 | ||
| Cost of revenue | $707.07 | $667.58 | ||
| Gross Profit | $572.43 | $448.58 | ||
| Operating activities | ||||
| Research & development | $25.57 | $25.22 | ||
| Selling, general & administrative | $335.63 | $152.09 | ||
| Total operating expenses | $368.1 | $203.35 | ||
| Operating income | $204.33 | $245.22 | ||
| Income from continuing operations | ||||
| EBIT | $211.09 | $77.98 | ||
| Income tax expense | $35.31 | $43.25 | ||
| Interest expense | $30.38 | $36.1 | ||
| Net income | ||||
| Net income | $145.4 | -$1.38 | ||
| Income (for common shares) | $145.4 | -$1.38 | ||
| (in millions $) | 31 Dec 2024 | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $5138.7 | $4957.84 | $3107.52 | |
| Cost of revenue | $2920.54 | $2798.15 | $1764.42 | |
| Gross Profit | $2218.16 | $2159.69 | $1343.1 | |
| Operating activities | ||||
| Research & development | $103.68 | $101.58 | $66.33 | |
| Selling, general & administrative | $1252.32 | $1298.88 | $731.32 | |
| Total operating expenses | $1382.04 | $1891.51 | $794.73 | |
| Operating income | $836.12 | $268.19 | $548.37 | |
| Income from continuing operations | ||||
| EBIT | $672.12 | $266.55 | $555.24 | |
| Income tax expense | $149.53 | $51.53 | $120.66 | |
| Interest expense | $144.35 | $107.99 | $37.18 | |
| Net income | ||||
| Net income | $378.24 | $107.03 | $397.4 | |
| Income (for common shares) | $378.24 | $107.03 | $397.4 | |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $145.4 | -$1.38 | $140.74 | |
| Operating activities | ||||
| Depreciation | $112.7 | $134.44 | $140.63 | |
| Business acquisitions & disposals | $795.91 | -$6.5 | ||
| Stock-based compensation | $11.46 | $8.95 | $15.29 | |
| Total cash flows from operations | $303.74 | $254.81 | $291.24 | |
| Investing activities | ||||
| Capital expenditures | -$108.08 | -$91.49 | -$118.92 | |
| Investments | $2.38 | |||
| Total cash flows from investing | $582.48 | $687.83 | -$95.61 | -$118.92 |
| Financing activities | ||||
| Dividends paid | -$107.67 | -$51.44 | -$51.4 | -$51.38 |
| Sale and purchase of stock | -$58.62 | $6.62 | -$1.44 | |
| Net borrowings | -$891.33 | -$99.02 | -$140.52 | |
| Total cash flows from financing | -$1179.9 | -$998.93 | -$143.77 | -$197.99 |
| Effect of exchange rate | $8.13 | -$1.33 | -$4 | $7.5 |
| Change in cash and equivalents | -$34.83 | -$8.69 | $11.44 | -$18.17 |
| (in millions $) | 31 Dec 2024 | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Net income | $378.24 | $107.03 | $243.89 | $397.4 |
| Operating activities | ||||
| Depreciation | $565.24 | $552.9 | $553.1 | $219.24 |
| Business acquisitions & disposals | -$536.8 | -$35.95 | -$380.74 | -$908.67 |
| Stock-based compensation | $56.53 | $38.95 | $57.66 | $25.97 |
| Total cash flows from operations | $973.27 | $756.95 | $684.81 | $689.64 |
| Investing activities | ||||
| Capital expenditures | -$352.94 | -$347.38 | -$285.82 | -$238.69 |
| Investments | $2.38 | -$4.4 | ||
| Total cash flows from investing | -$887.36 | -$383.33 | -$666.56 | -$1154.16 |
| Financing activities | ||||
| Dividends paid | -$200.57 | -$183.5 | -$163.17 | -$133.84 |
| Sale and purchase of stock | -$1.29 | -$306.74 | -$45.71 | $12.08 |
| Net borrowings | $121.49 | -$6.22 | $372.18 | $484.54 |
| Total cash flows from financing | -$85.19 | -$498.72 | $115.83 | $345.62 |
| Effect of exchange rate | -$2.06 | -$14.86 | -$6.29 | $19.85 |
| Change in cash and equivalents | -$1.34 | -$139.96 | $127.79 | -$99.05 |
News
Fundamentals
| Market cap | $20.31B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 98.71M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 0.75 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 2.41 |
| Quick ratio | 1.55 |